Hypoglycemic effects of Stachys affinis Bunge in streptozotocin-induced diabetic mice

Author:

Nguyen Thi Dung1ORCID,Mai Bich Dung2ORCID,Doan Thi Tam1,Vo Nguyen Thanh Thao1,Le Quang Luan1,Ha Thi Loan1

Affiliation:

1. Biotechnology Center of Ho Chi Minh City, Ho ChiMinh City, Vietnam

2. Institute of Biotechnology and Food Technology, Industrial University of Ho Chi Minh City, Ho ChiMinh City, Vietnam

Abstract

BACKGROUND: Stachys affinis Bunge (S. affinis) tubers are rich in carbohydrate with a large amount of stachyose which had been proven to have antidiabetic potential. OBJECTIVE: The present study aims to evaluate hypoglycemic effects of tuber extract of Stachys affinis in streptozotocin-induced diabetic mice. METHODS: The stachyose content of the extract was determined by UPLC. Diabetes was induced by the administration of single dose of streptozotocin (170 mg/kg). The hypoglycemic effects of the extract were evaluated by comparing fasting blood glucose level, glucose tolerance, insulin sensitivity between groups treated with the S. affinis tuber extract (at doses of 750 mg/kg and 1500 mg/kg) and diabetic control group over 28 days of treatment. RESULTS: The daily treatment with the extract at doses of 750 mg/kg and 1500 mg/kg significantly reduced fasting blood glucose level from 278.12 mg/dL to 127.50 mg/dL, and 238.97 mg/dL to 177.12 mg/dL (p < 0.01), respectively. Besides, the treatment also improved the sensitivity of diabetic treated mice to insulin (P < 0.05). CONCLUSION: The study revealed that the S. affinis tuber extract demonstrated significant hypoglycemic effects.

Publisher

IOS Press

Subject

Nutrition and Dietetics,Food Science,Endocrinology, Diabetes and Metabolism

Reference29 articles.

1. Standards of medical care in diabetes – 2019 abridged for primary care providers;American diabetes association;Clin Diabetes,2019

2. Complications of diabetes;Papatheodorou;J Diabetes Res,2018

3. Epidemiology of diabetes and diabetes-related complications;Deshpande;Physical Therapy,2008

4. Diabetes: What challenges lie ahead for Vietnam?;Ngoc;Ann Glob Health,2020

5. Clinical review of antidiabetic drugs: Implications for type 2 diabetes mellitus Management;Chaudhury;Front Endocrinol,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3